← Back to Search

Transcranial Magnetic Stimulation for Sensory Learning Studies

N/A
Recruiting
Led By Hannah J Block, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects must be between the ages of 18-45 years old and right-handed
Subjects must report being free of Covid symptoms in the week preceding testing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial is testing how well different techniques work to improve the accuracy of hand movements in people with damage to the sensorimotor areas of their brain.

Who is the study for?
This trial is for right-handed individuals aged 18-45, free of COVID symptoms and either fully vaccinated or with a recent negative test. Excluded are those with visual/hearing impairments, metal head implants (except titanium), severe hand/arm injuries, drug/alcohol use before testing, sleep deprivation, or certain medical conditions.Check my eligibility
What is being tested?
The study tests how brain stimulation using Theta burst transcranial magnetic stimulation affects sensorimotor learning. It aims to improve understanding of brain regions involved in maintaining accurate hand movements which could enhance rehabilitation for patients with brain lesions.See study design
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site, headache, lightheadedness, or temporary hearing changes due to the noise during the procedure. There's also a small risk of seizure but precautions are taken to minimize this.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 45 years old and right-handed.
Select...
I have not had any COVID-19 symptoms in the past week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Realignment
Secondary outcome measures
Motor cortex excitability (arms 1-3)
Tactile sensitivity (arms 1-3)
Target estimation variance
+2 more

Trial Design

7Treatment groups
Experimental Treatment
Placebo Group
Group I: Ventral premotor cortex--Exp 2Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over Ventral premotor cortex.
Group II: Somatosensory cortex--Exp 1Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over primary somatosensory cortex.
Group III: Primary motor cortex--Exp 1Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over primary motor cortex.
Group IV: Cerebellar cortex--Exp 2Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over cerebellar cortex.
Group V: Anterior superior parietal lobule--Exp 2Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over Anterior superior parietal lobule.
Group VI: Vertex sham--Exp 1Placebo Group1 Intervention
Sham theta burst transcranial magnetic stimulation (cTBS) will be applied over the vertex.
Group VII: Vertex sham--Exp 2Placebo Group1 Intervention
Sham theta burst transcranial magnetic stimulation (cTBS) will be applied over the vertex.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,860 Total Patients Enrolled
3 Trials studying Basic Science
520 Patients Enrolled for Basic Science
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,339 Previous Clinical Trials
649,090 Total Patients Enrolled
3 Trials studying Basic Science
520 Patients Enrolled for Basic Science
Hannah J Block, PhDPrincipal InvestigatorIndiana University, Bloomington

Media Library

Theta burst transcranial magnetic stimulation Clinical Trial Eligibility Overview. Trial Name: NCT05079516 — N/A
Basic Science Research Study Groups: Vertex sham--Exp 1, Primary motor cortex--Exp 1, Somatosensory cortex--Exp 1, Anterior superior parietal lobule--Exp 2, Ventral premotor cortex--Exp 2, Cerebellar cortex--Exp 2, Vertex sham--Exp 2
Basic Science Clinical Trial 2023: Theta burst transcranial magnetic stimulation Highlights & Side Effects. Trial Name: NCT05079516 — N/A
Theta burst transcranial magnetic stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05079516 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies to join this research study at present?

"According to the details available on clinicaltrials.gov, this medical trial is presently seeking participants. It was initially posted in late October 2021 and has since been updated at least once as of mid-October 2022."

Answered by AI

What criteria must potential participants satisfy to take part in this clinical trial?

"This trial is seeking a cohort of 150 individuals aged 18-45, who have no prior history with Covid. All potential subjects must be fully vaccinated or present a negative test within the last 4 days and report being free from infection symptoms in the week preceding testing. Further stipulations include right-handedness to circumvent any discrepancies between left and right arms as well as neurological effects caused by age differences outside of this range. Screening questions will be used to ensure that these requirements are met before enrolment."

Answered by AI

How many individuals is the trial recruiting at this time?

"Affirmative. The information on clinicaltrials.gov demonstrates that this study is currently enlisting participants; the trial was first featured October 26th 2021 and has been recently updated October 13th 2022. This research requires 150 patients from one site to partake in the experiment."

Answered by AI

Is the minimum age requirement for participants in this experiment eighteen years or older?

"According to the stated criteria, participants must be at least 18 years old and no older than 45."

Answered by AI

Who else is applying?

What state do they live in?
Indiana
How old are they?
18 - 65
What site did they apply to?
Indiana University Bloomington
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Average response time
  • < 1 Day
Typically responds via
Email
Most responsive sites:
  1. Indiana University Bloomington: < 24 hours
~57 spots leftby Dec 2024